Statement by Bayer's chief executive - Times Of India http://www.deccanherald.com/content/391614/medicines-rich-patients-only.html "India's controller general of patents angered Bayer in March 2012 when he authorized a local drugmaker to produce a generic copy of Nexavar, saying the German company charged a price that was too costly for most Indians. " We did not develop this medicine (Nexavar) for Indians ," Marijn Dekkers said at a little reported pharmaceutical forum last month, according to the January 21st edition of Businessweek. " We developed it for western patients who can afford it ," Dekkers said, and called the Indian regulator's action "essentially theft". Bayer said the statements attributed to Dekkers were accurate and forwarded written comments made later by the German chief executive seeking to explain his remarks. Dekkers said the comment had been a "quick response" at the indu
Indian Top Blog {2019, 2018, 2017, 2016 & 2015} for the past 5 years and counting; Nominated in top 5 Political Bloggers by Blogadda in Win-15. I specialise in deep politico-economic analysis; Books off the beaten track, and a value & fundamentals-based approach towards the Indian Economy, Corporate India - And Especially Indian Colonial History